| Q44619167 | A protease-resistant Escherichia coli asparaginase with outstanding stability and enhanced anti-leukaemic activity in vitro. |
| Q39406187 | Activation of the Nipah virus fusion protein in MDCK cells is mediated by cathepsin B within the endosome-recycling compartment. |
| Q64083428 | An annual cycle of gene regulation in the red-legged salamander mental gland: from hypertrophy to expression of rapidly evolving pheromones |
| Q34599128 | Analysis of tumour- and stroma-supplied proteolytic networks reveals a brain-metastasis-promoting role for cathepsin S |
| Q42064365 | Are cases of mumps in vaccinated patients attributable to mismatches in both vaccine T-cell and B-cell epitopes?: An immunoinformatic analysis |
| Q39044784 | Cathepsin B and L inhibitors: a patent review (2010 - present). |
| Q28259436 | Cathepsin B promotes colorectal tumorigenesis, cell invasion, and metastasis |
| Q42915550 | Cathepsin S causes inflammatory pain via biased agonism of PAR2 and TRPV4. |
| Q21132011 | Cathepsin S signals via PAR2 and generates a novel tethered ligand receptor agonist |
| Q108684885 | Characterising proteolysis during SARS-CoV-2 infection identifies viral cleavage sites and cellular targets with therapeutic potential |
| Q89900259 | Comprehensive draft of the mouse embryonic fibroblast lysosomal proteome by mass spectrometry based proteomics |
| Q38644377 | Computational investigation of conformational variability and allostery in cathepsin K and other related peptidases |
| Q91766933 | Coronavirus membrane fusion mechanism offers as a potential target for antiviral development |
| Q35592746 | Cysteine Cathepsins Activate ELR Chemokines and Inactivate Non-ELR Chemokines |
| Q64069431 | Cysteine Cathepsins and their Extracellular Roles: Shaping the Microenvironment |
| Q38644547 | Cysteine cathepsin proteases: regulators of cancer progression and therapeutic response |
| Q38182521 | Cysteine cathepsins and their potential in clinical therapy and biomarker discovery |
| Q26827307 | Cysteine cathepsins: their role in tumor progression and recent trends in the development of imaging probes |
| Q26771736 | Cysteine proteases as therapeutic targets: does selectivity matter? A systematic review of calpain and cathepsin inhibitors |
| Q38756684 | Cysteine proteases in atherosclerosis |
| Q41462476 | Deletion of cysteine cathepsins B or L yields differential impacts on murine skin proteome and degradome. |
| Q31117395 | Determinants of Macromolecular Specificity from Proteomics-Derived Peptide Substrate Data. |
| Q50868942 | Double deficiency of cathepsins B and L results in massive secretome alterations and suggests a degradative cathepsin-MMP axis. |
| Q34193957 | Droplet electrospray ionization mass spectrometry for high throughput screening for enzyme inhibitors |
| Q47548620 | Effects of Cross-Presentation, Antigen Processing, and Peptide Binding in HIV Evasion of T Cell Immunity. |
| Q39067283 | Emerging challenges in the design of selective substrates, inhibitors and activity-based probes for indistinguishable proteases |
| Q93000610 | Engineering mouse cationic trypsinogen for rapid and selective activation by cathepsin B |
| Q38417182 | Fast profiling of protease specificity reveals similar substrate specificities for cathepsins K, L and S. |
| Q35754294 | Fibroblast activation protein-α, a stromal cell surface protease, shapes key features of cancer associated fibroblasts through proteome and degradome alterations |
| Q38267389 | Frequency Patterns of T-Cell Exposed Amino Acid Motifs in Immunoglobulin Heavy Chain Peptides Presented by MHCs |
| Q90382676 | Human Cysteine Cathepsins Degrade Immunoglobulin G In Vitro in a Predictable Manner |
| Q51795887 | Human cathepsin L, a papain-like collagenase without proline specificity. |
| Q36764625 | Identification and prioritization of novel uncharacterized peptidases for biochemical characterization |
| Q36001454 | Identification of Protease Specificity by Combining Proteome-Derived Peptide Libraries and Quantitative Proteomics |
| Q88740659 | Imaging mass spectrometry reveals direct albumin fragmentation within the diabetic kidney |
| Q42371905 | In Silico Prediction Analysis of Idiotope-Driven T-B Cell Collaboration in Multiple Sclerosis |
| Q38557771 | Journey of cystatins from being mere thiol protease inhibitors to at heart of many pathological conditions |
| Q26749121 | Lysosomal cathepsins and their regulation in aging and neurodegeneration |
| Q64237341 | Neuroinflammation and fractalkine signaling in Alzheimer's disease |
| Q42682011 | Out-of-frame start codons prevent translation of truncated nucleo-cytosolic cathepsin L in vivo. |
| Q38531289 | Peptidase specificity from the substrate cleavage collection in the MEROPS database and a tool to measure cleavage site conservation |
| Q48364393 | Protease cleavage site fingerprinting by label-free in-gel degradomics reveals pH-dependent specificity switch of legumain. |
| Q38268345 | Proteolysis mediated by cysteine cathepsins and legumain-recent advances and cell biological challenges |
| Q30354466 | Proteolytic activation of the SARS-coronavirus spike protein: cutting enzymes at the cutting edge of antiviral research. |
| Q46099105 | Proteomic analysis of lung metastases in a murine breast cancer model reveals divergent influence of CTSB and CTSL overexpression. |
| Q38151761 | Proteomic identification of protease cleavage sites: cell-biological and biomedical applications |
| Q33356719 | Proteomic protease specificity profiling of clostridial collagenases reveals their intrinsic nature as dedicated degraders of collagen |
| Q34905953 | Recognition of higher order patterns in proteins: immunologic kernels |
| Q39208861 | Regulation of HLA-DR peptide occupancy by histone deacetylase inhibitors. |
| Q47152812 | Scavenger Receptor A Mediates the Clearance and Immunological Screening of MDA-Modified Antigen by M2-Type Macrophages |
| Q55023666 | Selective imaging of cathepsin L in breast cancer by fluorescent activity-based probes. |
| Q39621544 | Single Cell Chemical Cytometry of Akt Activity in Rheumatoid Arthritis and Normal Fibroblast-like Synoviocytes in Response to Tumor Necrosis Factor α. |
| Q36326605 | Targeting Cathepsin B for Cancer Therapies |
| Q41611232 | Trifluoperazine, a novel autophagy inhibitor, increases radiosensitivity in glioblastoma by impairing homologous recombination |
| Q91697408 | Trypsin Treatment Unlocks Barrier for Zoonotic Bat Coronavirus Infection |
| Q35913859 | Two Mutations Were Critical for Bat-to-Human Transmission of Middle East Respiratory Syndrome Coronavirus |